A 2-group experimental, repeated-measures design was used to compare HFCWO versus CPT with respect to lung transplant recipients’ pain and preference.
Group 1 received CPT as the first treatment followed by HFCWO.
Group 2 received HFCWO as the first treatment followed by CPT.